Current Stem Cell Research & Therapy

Scope & Guideline

Pioneering Research for a Healthier Future

Introduction

Welcome to the Current Stem Cell Research & Therapy information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Current Stem Cell Research & Therapy, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1574-888x
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 2006 to 2024
AbbreviationCURR STEM CELL RES T / Curr. Stem Cell Res. Ther.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

Current Stem Cell Research & Therapy focuses on advancing the understanding and therapeutic applications of stem cells across various medical domains. The journal emphasizes innovative research that explores the mechanisms, efficacy, and safety of stem cell therapies, while also addressing the challenges in regenerative medicine.
  1. Stem Cell Mechanisms and Pathways:
    Research exploring the underlying biological mechanisms of stem cells, including signaling pathways, differentiation processes, and the effects of various factors on stem cell behavior.
  2. Clinical Applications of Stem Cells:
    Studies focusing on the therapeutic applications of stem cells in treating various diseases, including but not limited to neurodegenerative disorders, cardiovascular diseases, and autoimmune conditions.
  3. Stem Cell Sources and Characteristics:
    Investigations into different sources of stem cells, such as mesenchymal stem cells, induced pluripotent stem cells, and embryonic stem cells, along with their unique properties and potential therapeutic uses.
  4. Exosomes and Secretome in Stem Cell Therapy:
    Research on the role of stem cell-derived exosomes and secretome in mediating therapeutic effects, including their potential in tissue repair and regeneration.
  5. Tissue Engineering and Regenerative Medicine:
    Studies involving the integration of stem cells with biomaterials and scaffolds to enhance tissue regeneration and repair in various medical applications.
  6. Safety and Efficacy of Stem Cell Therapies:
    Meta-analyses and systematic reviews assessing the safety, efficacy, and long-term outcomes of stem cell therapies in clinical settings.
The journal has witnessed an increase in research themes that highlight innovative approaches and emerging areas of interest in stem cell therapy. This section discusses the trending scopes that are shaping the future of the field.
  1. Exosome Research and Applications:
    There is a growing trend in the exploration of exosomes derived from stem cells, focusing on their roles in intercellular communication and potential as therapeutic agents in regenerative medicine.
  2. Combination Therapies Involving Stem Cells:
    Recent publications emphasize the use of stem cells in combination with other therapeutic modalities, such as gene therapy, nanomaterials, and pharmacological agents, to enhance treatment outcomes.
  3. Technological Advances in Stem Cell Research:
    The integration of advanced technologies, such as CRISPR gene editing, bioinformatics, and 3D bioprinting, is increasingly being recognized for its potential to revolutionize stem cell applications and tissue engineering.
  4. Personalized Medicine Approaches:
    Emerging themes highlight the personalization of stem cell therapies based on patient-specific factors, including genetic and epigenetic profiles, to optimize treatment efficacy and safety.
  5. Focus on Aging and Stem Cells:
    Research addressing the implications of aging on stem cell function and the development of therapies targeting age-related diseases is gaining momentum, reflecting an increasing interest in geriatric medicine.

Declining or Waning

As the field of stem cell research evolves, certain themes have shown a decline in prominence within the journal. This section highlights these waning scopes, which may reflect shifts in research focus or challenges in clinical application.
  1. Basic Science of Stem Cells:
    While foundational research on stem cell biology remains important, there has been a noticeable decline in publications focused solely on basic science without direct clinical implications, as the field moves towards more applied research.
  2. Non-Mesenchymal Stem Cell Applications:
    Research centered on non-mesenchymal stem cells, such as hematopoietic stem cells or embryonic stem cells, has decreased, possibly due to the increased focus on mesenchymal stem cells and their therapeutic versatility.
  3. In-vitro Studies Without Clinical Relevance:
    There has been a reduction in the publication of purely in-vitro studies that do not translate into clinical applications, as the journal emphasizes studies that demonstrate clear potential for therapeutic use.
  4. Single-source Stem Cell Studies:
    Research focusing on single-source stem cells (e.g., only one type of stem cell) is less common, reflecting a shift towards comparative studies that assess multiple stem cell types and sources for broader therapeutic implications.

Similar Journals

Cell Stem Cell

Pioneering Insights in Cellular Biology and Regenerative Medicine
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

CELL PROLIFERATION

Bridging Knowledge Gaps in Cell Proliferation Studies
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

Inflammation and Regeneration

Pioneering research at the intersection of inflammation and healing.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

Cell Journal

Transforming Knowledge into Breakthroughs in Cell Biology
Publisher: ROYAN INSTISSN: 2228-5806Frequency: 12 issues/year

Cell Journal is a leading interdisciplinary publication in the fields of Cell Biology, Developmental Biology, Molecular Biology, and Reproductive Medicine, published by ROYAN INST since its inception as an open-access journal in 2007. With an ISSN of 2228-5806 for print and 2228-5814 for electronic editions, it provides a vital platform for researchers and professionals to disseminate innovative findings and insights that shape our understanding of cellular processes and reproductive sciences. The journal boasts an impressive Scopus ranking, achieving a Q3 position in both Molecular Biology and Reproductive Medicine, highlighting its significance in the academic community. Situated in Tehran, Iran, Cell Journal encourages global collaboration through its accessible content, making cutting-edge research available to a diverse audience. As it converges from 2011 to 2024, the journal continues to emphasize the importance of thorough scientific inquiry, fostering advancements that drive both theoretical frameworks and practical applications in cell science.

Stem Cell Research & Therapy

Shaping the Future of Therapeutic Applications
Publisher: BMCISSN: Frequency: 1 issue/year

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.

Journal of Tissue Engineering and Regenerative Medicine

Advancing the frontiers of tissue engineering and regenerative medicine.
Publisher: WILEYISSN: 1932-6254Frequency: 12 issues/year

Journal of Tissue Engineering and Regenerative Medicine, published by WILEY, stands as a pivotal platform in the fields of biomaterials, biomedical engineering, and regenerative medicine. With an ISSN of 1932-6254 and an E-ISSN of 1932-7005, this journal, based in the United Kingdom, has consistently delivered high-quality research since its inception in 2006, converging critical insights through 2024. With an impressive citation profile reflected in its Scopus rankings—specifically a rank of #58 in Medicine and #75 in Biomedical Engineering—the journal is acknowledged for its substantial impact, as demonstrated by its competitive quartile standings in 2023. Notably, it maintains a Q3 ranking in Biomaterials and Q2 in both Biomedical Engineering and Medicine (miscellaneous), showcasing its influence and relevance in the rapidly evolving interplay between engineering and medicine. The journal serves as a vital resource for researchers and practitioners aiming to stay abreast of innovations and breakthroughs in regenerative therapies, tissue scaffolds, and biomaterials. While not an open-access publication, it fosters academic dialogue and knowledge dissemination that is crucial for advancing the field.

CYTOTECHNOLOGY

Transforming Knowledge: Your Gateway to Cutting-Edge Cytotechnological Research.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

Stem Cells and Cloning-Advances and Applications

Unlocking the Potential of Stem Cells and Cloning
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6957Frequency: 1 issue/year

Stem Cells and Cloning-Advances and Applications is a leading peer-reviewed journal dedicated to the dynamic fields of stem cell research and cloning technologies. Published by DOVE MEDICAL PRESS LTD in New Zealand since 2008, this Open Access journal ensures that groundbreaking findings are accessible to a global audience. With a focus on innovative applications and advancements in cellular biology, the journal plays a pivotal role in disseminating knowledge within the scientific community. The journal currently holds an impact factor that reflects its influence, with notable rankings in both Cell Biology and Medicine (Miscellaneous), showcasing its interdisciplinary relevance. Researchers, professionals, and students alike benefit from the journal’s wide-ranging contributions, covering critical topics from regenerative medicine to genetic research. With a commitment to fostering collaboration and encouraging discussion in these cutting-edge domains, Stem Cells and Cloning-Advances and Applications continues to be a vital resource for advancing scientific inquiry and application.

Cellular Reprogramming

Empowering Discovery in Biochemistry and Genetics
Publisher: MARY ANN LIEBERT, INCISSN: 2152-4971Frequency: 6 issues/year

Cellular Reprogramming is a prominent academic journal published by MARY ANN LIEBERT, INC, dedicated to advancing the field of cellular biology and biotechnology. With its ISSN 2152-4971 and E-ISSN 2152-4998, this journal provides an innovative platform for researchers and professionals to share groundbreaking research findings on cellular reprogramming, stem cell biology, and regenerative medicine. Established in 2010, and actively publishing until 2024, the journal is recognized for its contributions, evidenced by its categorizations in the Q3 and Q4 quartiles across several related fields, including biotechnology and developmental biology. This peer-reviewed journal not only supports open access to scientific literature but also aims to enhance interdisciplinary collaboration among scientists. With a growing impact in the realms of biochemistry, genetics, and molecular biology, Cellular Reprogramming remains an essential resource for the dissemination of pioneering research that could shape the future of cellular therapies.

International Journal of Stem Cells

Catalyzing Innovations in Stem Cell Applications
Publisher: KOREAN SOC STEM CELL RESEARCHISSN: 2005-3606Frequency: 2 issues/year

The International Journal of Stem Cells is a distinguished peer-reviewed journal dedicated to advancing the field of stem cell research. Published by the Korean Society for Stem Cell Research, this journal has established itself as a vital source of high-quality research since its inception in 2008. Operating under the ISSN 2005-3606 and E-ISSN 2005-5447, the journal caters to a global audience, featuring works that span a diverse array of topics within Cell Biology and Developmental Biology. It is noteworthy that as of 2023, the journal is ranked Q3 in Cell Biology and Q2 in Developmental Biology, highlighting its growing influence and credibility in the scientific community. Given its commitment to facilitating open scientific communication, it is crucial for researchers, professionals, and students to engage with the rigorous research published in this journal as it profoundly impacts the understanding and application of stem cell science. With accessibility to a wealth of innovative studies, the International Journal of Stem Cells remains an indispensable resource for anyone interested in the transformative potential of stem cell research.